本港累计近10.4万人已接种首剂疫苗
港府公布,於今年2月26日展开的2019冠状病毒病疫苗接种计划,截至昨日(8日)下午8时的过去24小时,约有9,900名市民接种第一剂科兴疫苗,当中约6,100人在八间社区疫苗接种中心接种,而约3,100人则在参与计划的私家医生和诊所接种。昨日在八间社区疫苗接种中心接种科兴疫苗的整体接种率达72%。
港府指,目前累计约10.38万名人士接种了第一剂疫苗,其中约10.17万名接种了科兴疫苗,约2,100名接种了复必泰疫苗。
截至昨日零时零分,过去24小时共有八宗送院个案,其中五宗无须留院,两宗已经出院,一宗留院观察。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.